Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig T Jordan

Showing results (71-80 of 164) with videos related to

Pageof 17
Sort By:
British Journal of Haematology|August 13, 2010
The NF (Nuclear factor)-κB inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7/JNK1-dependent apoptosis in human acute myeloid leukaemia cellsYun Dai, Monica L Guzman, Shuang Chen, et al.
Blood|February 29, 2008
Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression dataDuane C Hassane, Monica L Guzman, Cheryl Corbett, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 6, 2007
Group v secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered miceMeredith A Bostrom, Boris B Boyanovsky, Craig T Jordan, et al.
Bone Marrow Transplantation|October 14, 2021
Venetoclax and azacitidine followed by allogeneic transplant results in excellent outcomes and may improve outcomes versus maintenance therapy among newly diagnosed AML patients older than 60Daniel A Pollyea, Amanda Winters, Christine McMahon, et al.
Blood|September 6, 2007
Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8)Monica L Guzman, Xiaojie Li, Cheryl A Corbett, et al.
Molecular and Cellular Biology|December 3, 2003
Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesisIvan Topisirovic, Monica L Guzman, Melanie J McConnell, et al.
Cancer Investigation|July 12, 2011
Proteasome inhibition in myelodysplastic syndromes and acute myelogenous leukemia cell linesJane L Liesveld, Karen E Rosell, Jeremy Bechelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2019
Targeting Glutamine Metabolism and Redox State for Leukemia TherapyMark A Gregory, Travis Nemkov, Hae J Park, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2023
Parthenolide As a Therapeutic for Disseminated Canine NeoplasmsLisa J Schlein, Samuel A Brill, Rachel V Brady, et al.
Experimental Hematology|May 29, 2019
CD123 CAR T cells for the treatment of myelodysplastic syndromeBrett M Stevens, Wei Zhang, Daniel A Pollyea, et al.
Pageof 17

Showing results (71-80 of 164) with videos related to

Sort By:
Pageof 17
British Journal of Haematology|August 13, 2010
The NF (Nuclear factor)-κB inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7/JNK1-dependent apoptosis in human acute myeloid leukaemia cellsYun Dai, Monica L Guzman, Shuang Chen, et al.
Blood|February 29, 2008
Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression dataDuane C Hassane, Monica L Guzman, Cheryl Corbett, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 6, 2007
Group v secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered miceMeredith A Bostrom, Boris B Boyanovsky, Craig T Jordan, et al.
Bone Marrow Transplantation|October 14, 2021
Venetoclax and azacitidine followed by allogeneic transplant results in excellent outcomes and may improve outcomes versus maintenance therapy among newly diagnosed AML patients older than 60Daniel A Pollyea, Amanda Winters, Christine McMahon, et al.
Blood|September 6, 2007
Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8)Monica L Guzman, Xiaojie Li, Cheryl A Corbett, et al.
Molecular and Cellular Biology|December 3, 2003
Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesisIvan Topisirovic, Monica L Guzman, Melanie J McConnell, et al.
Cancer Investigation|July 12, 2011
Proteasome inhibition in myelodysplastic syndromes and acute myelogenous leukemia cell linesJane L Liesveld, Karen E Rosell, Jeremy Bechelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2019
Targeting Glutamine Metabolism and Redox State for Leukemia TherapyMark A Gregory, Travis Nemkov, Hae J Park, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2023
Parthenolide As a Therapeutic for Disseminated Canine NeoplasmsLisa J Schlein, Samuel A Brill, Rachel V Brady, et al.
Experimental Hematology|May 29, 2019
CD123 CAR T cells for the treatment of myelodysplastic syndromeBrett M Stevens, Wei Zhang, Daniel A Pollyea, et al.
Pageof 17